150881-71-3

Upstream product

• 286440-92-4 2-(3,4-difluorophenyl)ethan-1-ol 
• 321318-21-2 1-(3,4-difluorophenyl)ethan-1-ol 

Downstream Products

• 1160358-84-8 (R)-5-chloro-7-(1-(3,4-difluorophenyl)ethyl)-3-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7H-pyrazolo[3,4-b]pyridine 
• 1160358-85-9 (S)-5-chloro-7-(1-(3,4-difluorophenyl)ethyl)-3-(3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl)-7H-pyrazolo[3,4-b]pyridine 
• 1027085-82-0 3-(3,4-Difluoro-phenyl)-2-methylene-butyric acid ethyl ester 
• 155943-79-6 3-(3,4-Difluoro-phenyl)-2-methylene-butyric acid 
• 155943-49-0 2-[1-(3,4-Difluoro-phenyl)-ethyl]-malonic acid diethyl ester 
• 150881-50-8 (S)-2-[2-Acetylsulfanylmethyl-3-(3,4-difluoro-phenyl)-butyrylamino]-propionic acid benzyl ester 
• 150881-67-7 2-Acetylthiomethyl-3-[(3,4-difluoro)phenyl]butanoic Acid 

Relevant academic research and scientific papers

AZAINDOLE COMPOUNDS AND METHODS FOR TREATING HIV

Provided are compounds and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and their use for treating viral infections mediated by a member of the retrovirus family of viruses such as the Human Immunodeficiency Virus (HIV).

NOVEL OXABISPIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIAS

There is provided compounds of formula (I), wherein R1, R2, R3, R4, R 41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.

2″-deoxy hygromycin derivatives

This invention relates to compounds of the formula and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein R1and R2are as defined herein. The compounds of formula 1 are antibacterial and antiprotozoal agents that may be used to treat various bacterial and protozoal infections and disorders related to such infections. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods of treating bacterial and protozoal infections by administering the compounds of formula 1.